Cargando…

A novel peanut allergoid is safe and effective in immunotherapy in a peanut allergy mouse model

Detalles Bibliográficos
Autores principales:	Smit, J, Pieters, R, van Roest, M, Kruijssen, L, Koppelman, S, Opstelten, D-J, Van der Kleij, H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3723678/ http://dx.doi.org/10.1186/2045-7022-3-S3-P1

Ejemplares similares

Effect of modification of peanut conglutin on IgE and T cell reactivity in adults with peanut allergy
por: van Hoffen, Els, et al.
Publicado: (2011)

Non-digestible oligosaccharides scFOS/lcFOS facilitate safe subcutaneous immunotherapy for peanut allergy
por: Wagenaar, Laura, et al.
Publicado: (2019)

The individual role of peanut proteins Ara h1, 2, 3 and 6 in peanut allergy
por: Joost, Smit, et al.
Publicado: (2011)

sIgE to peanut components does not accurately predict the severity of allergy in subjects suspected of peanut allergy
por: Klemans, Rob, et al.
Publicado: (2015)

Secondary prevention of peanut allergy – continuous feeding or restriction of peanut protein
por: Bellach, J, et al.
Publicado: (2013)

Mouse strain differences in response to oral immunotherapy for peanut allergy
por: Wagenaar, Laura, et al.
Publicado: (2019)

Heterogeneous responses and cross reactivity between the major peanut allergens Ara h 1, 2,3 and 6 in a mouse model for peanut allergy
por: Smit, Joost J, et al.
Publicado: (2015)

Adhesion molecules in experimental peanut allergy
por: Bennett, Jami, et al.
Publicado: (2010)

Peanut Immunotherapy: Stepping Towards Desensitization for Peanut Allergy
por: Hsu, Joyce
Publicado: (2020)

Basophil allergen threshold sensitivity, and peanut allergen components in relation to DBPCFC in children with suspected peanut allergy
por: Nilsson, Caroline, et al.
Publicado: (2011)

A new OIT protocol for severe peanut allergy
por: Kukkonen, AK, et al.
Publicado: (2013)

Omalizumab as successful treatment option in severe peanut allergy
por: Dehlink, E, et al.
Publicado: (2013)

Improving diagnostic performances of peanut allergy using novel molecular components
por: Richard, Christelle, et al.
Publicado: (2014)

Basophil response to peanut allergens in the mediterranean area
por: Mayorga, C, et al.
Publicado: (2013)

Peanut allergy in France: preliminary results of the MIRABEL pilot study
por: Nguyen-Grosjean, VM
Publicado: (2013)

Should peanut allergy screening be introduced for all Irish children?
por: Kelleher, Maeve, et al.
Publicado: (2015)

Is allergy to peanuts and nuts a predictive factor for asthma development?
por: Zivanovic, Mirjana, et al.
Publicado: (2015)

Adjuvanted Immunotherapy Approaches for Peanut Allergy
por: Johnson-Weaver, Brandi T., et al.
Publicado: (2018)

Skin-testing protocol in diagnosing of the IgE-mediated peanut allergy
por: Behroo, Lotfollah, et al.
Publicado: (2015)

Dietary triglycerides profoundly affect oral sensitization to peanut protein in an adjuvant-free mouse model of peanut allergy
por: Eckhardt, Erik, et al.
Publicado: (2011)

Response to major peanut and peach allergens in a population of children allergic to peanut
por: Blanca, Miguel
Publicado: (2014)

Response to major peanut and peach allergens in a population of children allergic to peanut
por: Garcia-Blanca, Alexandra, et al.
Publicado: (2015)

The efficacy of oral and subcutaneous antigen-specific immunotherapy in murine cow’s milk- and peanut allergy models
por: Vonk, Marlotte M., et al.
Publicado: (2017)

Oral immunotherapy for peanut allergy: The pro argument
por: Chinthrajah, R. Sharon, et al.
Publicado: (2020)

Oral immunotherapy for peanut allergy: The con argument
por: Fiocchi, Alessandro, et al.
Publicado: (2020)

Peanut allergy: Beyond the oral immunotherapy plateau
por: Bruton, Kelly, et al.
Publicado: (2021)

Poster 1019: Novel allergy vaccine delivery system for poison ivy urushiol (PI) and peanut (PN)
por: Coifman, Robert, et al.
Publicado: (2014)

Usefulness of peanut and hazelnut molecular components for the diagnosis of nut allergy. Our experience in clinical practice
por: Rotiroti, Giuseppina, et al.
Publicado: (2011)

Increasing incidence of peanut allergy doubled in children from Bosnia and Herzegovnia during last decade
por: Bajraktarevic, Adnan, et al.
Publicado: (2011)

Dietary Supplementation with Nondigestible Oligosaccharides Reduces Allergic Symptoms and Supports Low Dose Oral Immunotherapy in a Peanut Allergy Mouse Model
por: Wagenaar, Laura, et al.
Publicado: (2018)

Peanut Allergy: An Overview
por: Al-Ahmed, Nasser, et al.
Publicado: (2008)

Peanut allergy may be overdiagnosed in younger siblings of those with confirmed peanut allergy
por: Lavine, Elana, et al.
Publicado: (2014)

Importance of Ara h 6 in peanut allergy diagnosis
por: Pedrosa, Maria, et al.
Publicado: (2014)

T cell specific and non specific tolerance mechanisms in peanut oil immunotherapy in peanut allergic subjects
por: Singh, Amit, et al.
Publicado: (2011)

The molecular effects of processing on the peanut allergens
por: Maleki, Soheila
Publicado: (2014)

First results of MIRABEL: a research program to develop tools for risk and cost/benefit analysis of peanut allergy
por: Crépet, A, et al.
Publicado: (2013)

Peanut immunotherapy
por: Anagnostou, Katherine, et al.
Publicado: (2014)

Atopic dermatitis increases the effect of exposure to peanut antigen in dust on peanut sensitization and likely peanut allergy
por: Brough, Helen A., et al.
Publicado: (2015)

IgE-levels to peanut allergen component Ara h 2: relation to peanut symptoms in 8-year-olds
por: Asarnoj, A, et al.
Publicado: (2013)

Specific IgE to Ara h 2 is the best predictor for peanut allergy in adults and is correlated to clinical severity
por: Klemans, R, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_fmr1hrpnv0ifjclph6hr5r5ukn